SSY Group Ltd. | Ownership

Companies that own SSY Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
45,800,554
1.52%
2,814,000
0%
07/31/2018
UBS Asset Management (Hong Kong) Ltd.
36,608,940
1.22%
0
0.78%
06/13/2018
BlackRock Fund Advisors
34,506,411
1.14%
0
0%
09/06/2018
Dimensional Fund Advisors LP
33,286,502
1.1%
0
0.01%
04/30/2018
Norges Bank Investment Management
27,509,472
0.91%
2,344,072
0%
12/31/2017
FIL Investment Management (Hong Kong) Ltd.
24,687,863
0.82%
2,191
0.1%
05/31/2018
Nordea Investment Management AB (Denmark)
15,126,387
0.5%
168,473
0.02%
05/31/2018
UBS Asset Management (Singapore) Ltd.
5,883,925
0.2%
53,191
0.21%
04/20/2017
BlackRock Advisors (UK) Ltd.
5,727,227
0.19%
0
0%
09/06/2018
China Asset Management Co., Ltd.
5,678,000
0.19%
2,960,000
0.03%
03/31/2018

About SSY Group

View Profile
Address
Rooms 4902-03, 49th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.ssygroup.com.hk
Updated 07/08/2019
SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: Intravenous Infusion Solution and Others; and Medical Materials. The company was founded on September 28, 2004 and is headquartered in Hong Kong.